NCT06841770View on ClinicalTrials.gov

A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

August 10, 2027

Study Completion Date

June 30, 2037

Conditions
Spinal Cord Injury CervicalSpinal Cord Injury ThoracicSpinal Cord Injury, AcuteSpinal Cord InjurySpinal Cord Injury, Chronic
Interventions
BIOLOGICAL

OPC1

One injection of 10 million LCTOPC1 cells will be delivered to the target injection site of the damaged spinal tissue.

Trial Locations (1)

92037

RECRUITING

University of California, San Diego, La Jolla

Sponsors
All Listed Sponsors
lead

Lineage Cell Therapeutics, Inc.

INDUSTRY

NCT06841770 - A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury | Biotech Hunter | Biotech Hunter